Cargando…
Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy
The conventional procedure for the construction of recombinant expression vector of a target gene includes PCR cloning and restriction enzyme mediated subcloning, which is time-consuming and sometimes troublesome because of the inefficiency of ligation. A variety of ligase-independent PCR cloning st...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433943/ https://www.ncbi.nlm.nih.gov/pubmed/28510221 http://dx.doi.org/10.1186/s13568-017-0386-1 |
_version_ | 1783236939293392896 |
---|---|
author | Cao, Liting Zhou, Yancheng Huang, Lin Dong, Shiqi Ma, Yue |
author_facet | Cao, Liting Zhou, Yancheng Huang, Lin Dong, Shiqi Ma, Yue |
author_sort | Cao, Liting |
collection | PubMed |
description | The conventional procedure for the construction of recombinant expression vector of a target gene includes PCR cloning and restriction enzyme mediated subcloning, which is time-consuming and sometimes troublesome because of the inefficiency of ligation. A variety of ligase-independent PCR cloning strategies have been developed, but they either involve complicated PCR procedures or need other DNA modifying enzymes. In this study, we report the design, and construction of an omnipotent expression vector pOmni, with which a target gene can be easily cloned through innovative selection-free PCR recombination cloning strategy with only one pair of primer and two times of PCR in one work day, without using any restriction enzymes, ligase and other DNA modifying enzymes. Furthermore, the target gene cloned in pOmni is ready to be high-efficiently expressed in either Escherichia coli cells or eukaryotic cells because of the elaborate design of compatible T7 promoter and CMV promoter expression elements in the vector. The cloning capability and reliability of selection-free PCR recombination cloning with pOmni were validated through cloning of 6 DNA fragments with length from 315 to 4557 bp, and the dual-expression function of the vector was verified through the cloning and expression of EGFP in E. coli BL21 and HeLa cells. pOmni developed in our study provides a powerful tool for gene cloning and expression, and is of special value for researches in which both prokaryotic and eukaryotic expression of a target gene are necessary. |
format | Online Article Text |
id | pubmed-5433943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-54339432017-05-31 Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy Cao, Liting Zhou, Yancheng Huang, Lin Dong, Shiqi Ma, Yue AMB Express Original Article The conventional procedure for the construction of recombinant expression vector of a target gene includes PCR cloning and restriction enzyme mediated subcloning, which is time-consuming and sometimes troublesome because of the inefficiency of ligation. A variety of ligase-independent PCR cloning strategies have been developed, but they either involve complicated PCR procedures or need other DNA modifying enzymes. In this study, we report the design, and construction of an omnipotent expression vector pOmni, with which a target gene can be easily cloned through innovative selection-free PCR recombination cloning strategy with only one pair of primer and two times of PCR in one work day, without using any restriction enzymes, ligase and other DNA modifying enzymes. Furthermore, the target gene cloned in pOmni is ready to be high-efficiently expressed in either Escherichia coli cells or eukaryotic cells because of the elaborate design of compatible T7 promoter and CMV promoter expression elements in the vector. The cloning capability and reliability of selection-free PCR recombination cloning with pOmni were validated through cloning of 6 DNA fragments with length from 315 to 4557 bp, and the dual-expression function of the vector was verified through the cloning and expression of EGFP in E. coli BL21 and HeLa cells. pOmni developed in our study provides a powerful tool for gene cloning and expression, and is of special value for researches in which both prokaryotic and eukaryotic expression of a target gene are necessary. Springer Berlin Heidelberg 2017-05-16 /pmc/articles/PMC5433943/ /pubmed/28510221 http://dx.doi.org/10.1186/s13568-017-0386-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Cao, Liting Zhou, Yancheng Huang, Lin Dong, Shiqi Ma, Yue Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title | Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title_full | Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title_fullStr | Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title_full_unstemmed | Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title_short | Development of a dual-expression vector facilitated with selection-free PCR recombination cloning strategy |
title_sort | development of a dual-expression vector facilitated with selection-free pcr recombination cloning strategy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433943/ https://www.ncbi.nlm.nih.gov/pubmed/28510221 http://dx.doi.org/10.1186/s13568-017-0386-1 |
work_keys_str_mv | AT caoliting developmentofadualexpressionvectorfacilitatedwithselectionfreepcrrecombinationcloningstrategy AT zhouyancheng developmentofadualexpressionvectorfacilitatedwithselectionfreepcrrecombinationcloningstrategy AT huanglin developmentofadualexpressionvectorfacilitatedwithselectionfreepcrrecombinationcloningstrategy AT dongshiqi developmentofadualexpressionvectorfacilitatedwithselectionfreepcrrecombinationcloningstrategy AT mayue developmentofadualexpressionvectorfacilitatedwithselectionfreepcrrecombinationcloningstrategy |